Study 01
Human phase 2Once-weekly cagrilintide for weight management: a dose-finding phase 2 trial
The Lancet · 2021
What researchers examined
A multicentre, randomized, double-blind study of a long-acting amylin analogue.
How to interpret it
Phase 2 studies are generally exploratory or dose-finding. They help characterize signals and adverse events but do not by themselves establish broad safety or effectiveness.